Compare The United Laboratories International Holdings Ltd. with Similar Stocks
Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 15.26%
- Healthy long term growth as Operating profit has grown by an annual rate 23.13%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 35.84
2
With ROE of 18.81%, it has a Very Attractive valuation with a 1.51 Price to Book Value
3
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-27.45%
0%
-27.45%
6 Months
-23.68%
0%
-23.68%
1 Year
-31.29%
0%
-31.29%
2 Years
-5.49%
0%
-5.49%
3 Years
37.85%
0%
37.85%
4 Years
139.57%
0%
139.57%
5 Years
26.38%
0%
26.38%
The United Laboratories International Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.79%
EBIT Growth (5y)
23.13%
EBIT to Interest (avg)
35.84
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.84
Tax Ratio
19.19%
Dividend Payout Ratio
39.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.45%
ROE (avg)
15.26%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
1.51
EV to EBIT
5.73
EV to EBITDA
4.83
EV to Capital Employed
1.73
EV to Sales
1.36
PEG Ratio
8.04
Dividend Yield
NA
ROCE (Latest)
30.21%
ROE (Latest)
18.81%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
14,327.20
14,917.80
-3.96%
Operating Profit (PBDIT) excl Other Income
3,166.50
3,757.60
-15.73%
Interest
75.60
37.90
99.47%
Exceptional Items
92.30
74.50
23.89%
Consolidate Net Profit
2,257.00
2,881.70
-21.68%
Operating Profit Margin (Excl OI)
171.80%
207.10%
-3.53%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -3.96% vs -1.74% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -21.68% vs -3.44% in Dec 2024
About The United Laboratories International Holdings Ltd. 
The United Laboratories International Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






